IP Library Granted Patent US 7,628,984
Granted Patent B2
US 7,628,984 · App. 12/157,077 · Granted Dec 8, 2009

Micronutrient formulations for pulmonary and heart health

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,628,984
App. No.
12/157,077
Granted
Dec 8, 2009
Kind
B2
Abstract

A heart and pulmonry health micronutrient formulation is provided and the formulation comprises dietary antioxidants and endogenous antioxidants, and the formulation comprising dietary micronutrients and endogenous antioxidants, the dietary antioxidants are selected from a group consisting essentially of Vitamin A (Palmitate), Vitamin E, Vitamin C, Vitamin D 3 (Cholecalciferol), B Vitamins, Biotin, Pantothenic Acid (as D-Calcium Pantothenate), Calcium Citrate, Magnesium Citrate, Zinc Glycinate, Selenium (Seleno-L-Methionine), Chromium (as Chromium Picolinate), Mixed Carotenoids and mixtures thereof, and the endogenous antioxidants are selected from a group consisting essentially of N-Acetyl Cysteine (NAC), Coenzyme Q 10 , R-alpha Lipoic Acid, Omega-3 fatty Acid, and L-Carnitine and mixtures thereof.

Claims (32)

1. A micronutrient formulation consisting of first and second compositions, said first composition consisting of:

Vitamin A (Palmitate) from about 3,000 to about 5000 IU

Vitamin E from about 50 to about 400 IU

Buffered Vitamin C (Calcium Ascorbate) from about 100 to about 4,000 mg

Vitamin C from about 100 to about 4,000 mg

Vitamin D 3 (Cholecalciferol) from about 400 to about 600 IU

Vitamin B 1 (Thiamine Mononitrate) from about to 2 about 10 mg

Vitamin B 2 (Riboflavin) from about 2 to about 20 mg

Vitamin B 3 (Niacinamide Ascorbate) from about 15 to about 200 mg

Vitamin B 6 (Pyridoxine Hydrochloride) from about 2 to about 10 mg

Folic Acid from about 400 to about 1500 mcg

Vitamin B 12 (Cyanocobalamln) from about 5 to about 20 mcg

Biotin from about 100 to about 500 mcg

Pantothenic Acid (as D-Calcium Pantothenate) from about 5 to about 30 mg

Calcium Citrate from about 100 to about 500 mg

Magnesium Citrate from about 100 to about 250 mg

Zinc Glycinate from about 10 to about 30 mg

Selenium (Seleno-L-Methionine) from about 50 to about 200 mcg

Chromium (as Chromium Picolinate) from about 50 to about 200 mcg,

said second composition consisting of:

N-Acetyl Cysteine (NAC) from about 100 to about 500 mg

Coenzyme Q 10 from about 10 to about 250 mg

Alpha Lipoic Acid from about 15 to about 100 mg

Omega-3 Fatty Acid from about 1,000 to about 4,000 mg

L-Carnitine from about 50 to about 500 mg and

Natural Mixed Carotenoids from about 10 to about 20 mg and

wherein said formulation is designed to treat heart and pulmonary diseases and disorders.

2. The formulation of claim 1 wherein Vitamin E is selected from a group consisting of d-alpha Tocopheryl Succinate from about 50 to about 400 IU, d-alpha Tocopheryl Acetate from about 50 to about 400 IU and mixtures thereof, and wherein said mixed carotenoids are selected from a group consisting of natural sources of algae, alpha carotene, beta carotene, gamma carotene, lutein, lycopene, xynthines, beta-cryptoxanthin, zeaxanthin, astaxanthin, phytoene, canthaxanthin, fucoxanthin and mixtures thereof.

3. The formulation of claim 1 wherein said formulation is consumed by the user at least twice per day.

4. The formulation of claim 1 wherein said formulation is consumed by the user prior to diagnosis of pulmonary and heart related diseases.

5. The formulation of claim 1 wherein said formulation is consumed by the user for long term maintenance after diagnosis of pulmonary and heart diseases.

6. The formulation of claim 5 wherein long term maintenance is from about at least one week to about life long.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2022
From: JGB COLLATERAL, LLC
To: NABC, INC.
Reel/Frame 059383/0122 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: EAST WEST BANK
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
Reel/Frame 054733/0587 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2020
From: EAST WEST BANK
To: NEWAGE, INC.; NABC, INC.; MORINDA, INC.
Reel/Frame 054560/0232 →
SECURITY INTEREST Recorded Dec 1, 2020
From: ARIEL MERGER SUB 2, LLC; NEWAGE, INC. (A WASHINGTON CORPORATION); NABC, INC.; MORINDA, INC.
To: JGB COLLATERAL, LLC (A DELAWARE LIMITED LIABILITY COMPANY)
Reel/Frame 054509/0837 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2019
From: DOMINION CAPITAL LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048793/0288 →
SECURITY INTEREST Recorded Apr 1, 2019
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
To: EAST WEST BANK
Reel/Frame 048752/0082 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2019
From: SIENA LENDING GROUP LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048752/0034 →
SECURITY INTEREST Recorded Aug 13, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES CORPORATION
To: SIENA LENDING GROUP LLC
Reel/Frame 046623/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2018
From: PREMIER MICRONUTRIENT CORPORATION
To: NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 046599/0450 →
SECURITY INTEREST Recorded Jun 22, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
To: DOMINION CAPITAL LLC
Reel/Frame 046181/0389 →
SECURITY AGREEMENT Recorded Jan 23, 2010
From: PREMIER MICRONUTRIENT CORPORATION
To: FIRSTBANK
Reel/Frame 023832/0785 →